AI-based sensors for pathogen detection combine machine learning (ML) and deep learning (DL) with biosensing platforms for rapid, accurate, real-time pathogen identification in food, water and clinical samples. These systems improve sensitivity by reducing background noise and analyzing data from electrochemical, optical or microfluidic sensors, with detection times as short as 10 minutes. Rapid pathogen detection supports food safety and public health. In microbial studies, AI-based image analysis can improve pathogen classification and counting in mixed cultures.
The report includes:
- Impact analysis of artificial intelligence (AI) on the U.S. biodefense-related rapid pathogen identification and treatments market
- Case studies for successful integration of AI and machine learning in detection devices and sensors
- Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI across detection and diagnosis, prevention, and treatment
- AI’s role in academic and research institutes, government and defense agencies, hospitals, and pharma and biotechnology companies
- Competitive landscape featuring key strategic initiatives, market spendings and an investment outlook
Table of Contents
Chapter 1 Key Use Cases for AI Implementation- Overview
- Key Use Case
- Use Case 1: AI-Based Real-Time Biological Threat Monitoring
- Use Case 2: Community-Level Surveillance of Wastewater
- Use Case 3: Infectious Disease Detection Using AI and Genomics Data
- Adoption Trends in the U.S.
- Impact of AI on Key Industry Verticals
- Detection and Identification
- Development of Medical Countermeasures
- Public Health Organizations and Hospitals
- Impact of AI on Various Stages of the Value Chain
- Research and Development (R&D)
- Manufacturing and Scaling
- Field Deployment
- Market Spending and Forecasting Analysis
- VC Investment for AI in U.S. Biodefense-Related Pathogen Identification and Treatments
- Abbreviations Used in the Report
Table 1: Examples of the U.S. Government Agencies' AI-Based Biodefense Programs
Table 2: Examples of Investments in AI in the U.S. Biodefense-Related Pathogen Identification and Treatments Market, 2024-2026*
Table 3: Abbreviations Used in This Report
